The FDA has authorized treatments to curb the progression of COVID-19 in people who are not hospitalized but who are at risk for developing severe illness.
There are multiple anti-SARS-CoV-2 products that can be used for treatment or prophylaxis of COVID-19 that have received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA).
Many people who have coronavirus disease 2019 (COVID-19) recover completely within a few weeks, but some people continue to experience symptoms for four or more weeks.
Find out more information about COVID-19 treatment options.